| Ytd | -40.82% | |
| 1y | -81.95% |
| Open | 9.46 | Prev Close | 9.38 | Low | 9.16 | High | 10.00 | Mkt Cap | 401.31M |
| Vol | 1.10M | Avg Vol | 253.60K | EPS | -3.37 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.32 | Short Ratio | 1.15 | Inst. Own | 18.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 7.56 | 200-d Avg | 12.65 | 1yr Est | 0.00 |
SUPX News
SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the
SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the
SINGAPORE, Aug. 25, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the
The text discusses recent gains in the stock market, particularly for companies like Napco Security
SuperX AI Technology Limited ("SuperX" or the "Company"), a full-stack AI infrastruc
On August 6, 2026, the Company's board of directors authorized a share repurchase program under
On June 25, 2026, SuperX AI Technology Limited (the "Company") entered into two material cor
SuperX AI Technology Limited (NASDAQ:SUPX), a NASDAQ-listed full-stack AI infrastructure solutions p
SuperX AI Technology Limited (NASDAQ:SUPX, ", SuperX", or the ", Company", ))), an e
SuperX AI Technology Limited ("SuperX" or the "Company"), a full-stack AI infrastruc
SuperX AI Technology Limited (NASDAQ:SUPX) ("SuperX" or the "Company"), an emerging
Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data.
